In people with apparent treatment-resistant hypertension, dapagliflozin safely improves outcomes: DELIVER Trial.

Published Date: 16 Oct 2023

USA: Dapagliflozin was found to be well tolerated and to consistently improve clinical outcomes, including, in a post hoc analysis of the DELIVER trial.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

2.

Chris Hoy reveals that he has terminal cancer?here's how to spot early signs of prostate cancer

3.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

4.

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

5.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot